Summary & Overview
HCPCS J2175: Injection, Meperidine Hydrochloride, per 100 mg
HCPCS Level II code J2175 denotes an injectable dose of meperidine hydrochloride, billed per 100 mg. As a drug-specific HCPCS code, it is used to report parenteral administration of meperidine in acute and outpatient care settings where injectable opioid analgesics are provided. This code matters nationally because it enables standardized reporting and reimbursement for meperidine use across hospitals, emergency departments, ambulatory surgery centers, and clinics.
Key payers in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of the clinical context for meperidine use, typical sites of service, and the role of HCPCS coding in drug billing. The publication outlines benchmark considerations for per-unit billing, payer coverage patterns (where available), and common administrative practices tied to injectable pharmaceuticals.
The report provides actionable reference material for billing professionals and revenue cycle staff: how J2175 is recorded on claims, the service settings where it commonly appears, and the elements payers review when adjudicating meperidine injections. Data not available in the input is identified explicitly where applicable, and the content focuses on national implications rather than state-level details.
Billing Code Overview
HCPCS Level II code J2175 represents an injection of meperidine hydrochloride, per 100 mg. This billing code describes a single drug administration unit of meperidine hydrochloride used for analgesia.
Service Type: Drug administration (injectable opioid analgesic)
Typical Site of Service: Inpatient hospital, outpatient hospital, emergency department, ambulatory surgical center, and clinic settings where parenteral analgesics are administered.
Clinical & Coding Specifications
Clinical Context
A 56-year-old male presents to the emergency department with acute, severe abdominal pain following a minor motor vehicle collision. He has a history of chronic pancreatitis with intermittent acute flares. After triage and clinician evaluation, the physician orders parenteral analgesia for moderate-to-severe pain where oral agents are not tolerated. The treatment plan includes administration of an opioid analgesic via intramuscular or intravenous injection in the ED. Pharmacy prepares meperidine hydrochloride in a dose corresponding to J2175 (per 100 mg). Nursing documents medication administration in the EHR, records vital signs and pain scores before and after administration, and monitors for adverse effects (respiratory depression, hypotension, sedation). Billing staff link the administered units of J2175 to the encounter, append appropriate diagnosis pointers reflecting the cause of pain, and add clinically appropriate modifiers for billing (for example, modifier 25 if a significant, separately identifiable evaluation and management service is provided during the same visit). Typical sites of service include hospital emergency departments, outpatient hospital observation units, ambulatory surgery centers (when used intraoperatively or post-anesthesia), and inpatient acute care units when the agent is administered by nursing or anesthesia staff.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|